West Pharmaceutical Services, Inc.
WST
$352.65
$0.520.15%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 10.95% | 5.07% | -5.64% | 6.22% | 46.77% |
| Total Depreciation and Amortization | 2.21% | -3.83% | 9.30% | 3.86% | 3.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.36% | 190.72% | -180.17% | 51.25% | 1,700.00% |
| Change in Net Operating Assets | 16.42% | -225.95% | 3,790.48% | 151.22% | -4,200.00% |
| Cash from Operations | 37.93% | -64.20% | 27.33% | 11.35% | 36.86% |
| Capital Expenditure | -1.17% | 43.89% | -20.22% | 15.82% | -5.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.17% | 43.89% | -20.22% | 15.82% | -5.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -16,700.00% | 0.00% | 0.00% | 0.00% | -50.00% |
| Issuance of Common Stock | 17.33% | 63.04% | 15.00% | -23.08% | 18.18% |
| Repurchase of Common Stock | 47.78% | -149,950.00% | -100.00% | 80.00% | 99.63% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.63% | 0.00% | -4.64% | 0.00% | 0.66% |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | 46.61% | -2,538.46% | -1.74% | 22.82% | 89.86% |
| Foreign Exchange rate Adjustments | 80.95% | -1,580.00% | 86.11% | -119.46% | 117.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.28% | -265.79% | 37.04% | 12.61% | 231.22% |